Polygenic Scores Show Limited Value in Cardiovascular Risk Prediction for Breast Cancer Survivors

Approximately 4 million women in the United States are living with breast cancer, a number that reflects advances in screening and treatment. As survivorship improves, attention has increasingly shifted toward long-term risks such as cardiovascular disease (CVD), a leading cause of mortality in this population and a growing concern within the VA, given the increasing number of women veterans.

MRI-Guided TMS Improves Outcomes in Combat-Related PTSD Trial

Combat-related post-traumatic stress disorder (PTSD) is one of the most difficult mental health conditions to treat among military personnel and veterans. Although trauma-focused psychotherapies help many patients recover, some continue to experience severe symptoms despite intensive treatment.

Should the disorder infect the Army in the natural way, we should have more to dread from it than from the Sword of the Enemy

Gen. George Washington penned this month’s quote in a 1777 letter to Dr. William Shippen Jr., the Continental Army’s medical director, ordering all Philadelphia recruits for the Continental Army to be inoculated for smallpox. Washington had personal experience with the disease, contracting the virus on a visit to Barbados in 1751, marking him with scars but providing him with lifelong immunity to the disease. As a military commander, Washington witnessed how the scourge of smallpox could burn through his army and devastate combat effectiveness. During the ill-fated winter campaign in Canada (1775-1776), more revolutionary soldier casualties were due to smallpox than enemy fire.

RSV Vaccines Protect Veterans Well But Repeat Jabs Might Be Needed

Because of an older population of veteran patients, many with numerous co-morbidities, the VA recognizes respiratory syncytial virus (RSV) as a serious threat. Three RSV vaccines are currently approved for adults in the United States; the latest is an mRNA-based vaccine. While all three have demonstrated meaningful protection against RSV-associated lower respiratory tract disease (LRTD), concerns have been raised about the durability of some of them and whether repeat shots might be required.

Expert Panel Recommended Regular Review of Psychotropic Medications

Psychotropic medications are often prescribed for many complex, difficult-to-treat psychiatric disorders and include antidepressants, anti-anxiety agents, antipsychotics, mood stabilizers and stimulants. New guidance has suggested there’s a need for greater recognition of clinical psychopharmacology endpoints.

Multiple Myeloma Survival Lower Than Previously Reported, but Powerful New Later Line Options Offer Hope

Including survival statistics for the nonmalignant precursor of multiple myeloma (MM), smoldering multiple myeloma, has led to a significant overestimation of 5-year survival patients with MM. But the news is not all bad. Recent approval of powerful new later line options are offering hope for patients who have tried multiple therapies are offering hope for more durable survival.

Cancer Vaccines in Lung Cancer: A New Strategy to Overcome Immunotherapy Resistance

Immune checkpoint inhibitor (ICI) resistance can be caused by tumor evasion mechanisms that prevent T cells from recognizing or killing cancer cells. Cancer vaccines are designed to address those challenges by stimulating the immune system to recognize tumor-specific antigens. Unlike preventive vaccines, these therapeutic approaches can “induce de novo or amplify pre-existing tumor-specific immune responses, thereby enhancing long-term immunological memory while maintaining a favorable safety profile,” according to a new study.

Acalabrutinib Gains Ground as Preferred BTK Inhibitor for CLL/SLL in Veterans Likely to Have Co-Morbidities

Veterans with chronic lymphocytic leukemia and small lymphocytic leukemia tend to be very different than typical clinical trial populations, presenting with diagnoses of hypertension, type 2 diabetes, chronic kidney disease, obstructive sleep apnea, and post-traumatic stress disorder, among other conditions. That is why VA’s oncology clinical pathways now prefer a first-line therapy that has demonstrated efficacy across high-risk genomic subgroups, has a lower rate of adverse effects and is compatible with the complex comorbidity profile common among older veterans.

More Genetic Testing, New Drug Combinations Hold Promise for Prostate Cancer With Germline Variants

Pathogenic germline variants might be found in a relatively small percentage of prostate cancer patients, but they can make the prognosis much, much worse. Now, the future is looking brighter, with the VA and other healthcare systems spearheading more testing. At the same time, drug combinations involving PARP inhibitors are showing some success in lengthening survival.

B-Cell Lymphomas in Veterans: Expanding the Role of Next-Generation BTK Inhibition

The PACT Act marked the largest single expansion of veterans’ benefits for toxic exposure in the history of the VA. Among its most consequential provisions for hematology-oncology care, the legislation established lymphomas of any type as presumptive service-connected conditions for veterans who served in qualifying locations during the Gulf War era or in the post-September 11, 2001, conflicts.

Veterans With ALS Report High Satisfaction With VA Care Compared to Outside Care

Veterans With ALS Report High Satisfaction With VA Care Compared to Outside Care

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurogenerative disease that has devastating symptoms. It is 1.5 times more common in military veterans than those who never served. A recent survey found that veterans with the disease gave high marks to VA’s highly comprehensive and coordinated system to manage their care.